M

Researcher Profile

M Marrah

3

Publications

172

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article The Lancet Global Health Nov 01, 2023

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

Edward Man-Lik Choi · Boris Lacarra · Muhammed O Afolabi · Boni Maxime Ale +282 more

10.1016/s2214-109x(23)00410-2 13 citations

Open Access Journal Article The Lancet Infectious Diseases Jan 01, 2022

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O Afolabi · David Ishola · Daniela Manno · Babajide Keshinro +333 more

10.1016/s1473-3099(21)00128-6 80 citations

Open Access Journal Article The Lancet Infectious Diseases Jan 01, 2022

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola · Daniela Manno · Muhammed O Afolabi · Babajide Keshinro +327 more

10.1016/s1473-3099(21)00125-0 79 citations

Publication Timeline

2023

1

2022

2

Frequent Co-Authors

Babajide Keshinro